Inheritance being cashed in: management is converting a long-held position into current business on purpose
The model's full reasoning — Q4 2017 call → NOWe need to determine if management describes deliberately converting something long-held into current business, with real present-tense business coming from it, and that it's still early relative to what it can yield. Key candidates: - The J&J partnership: It was formed in 2016/2017, so it's relatively new, not long-held. - The manufacturing capacity in UK: They are building it, not converting something old. - The nerve block data: They have studies, but that's regulatory, not conversion. - The "Surgeon Selector" tool, website, etc. - The "Choices Matter" program? - The "DepoMeloxicam" is new. - The "DepoTranexamic Acid" is being discontinued. - The "EXPAREL" itself? They have been selling it for years. - The "C-section study" is ongoing. - The "partnerships" with WellStar, CTCA, etc. are new. - The "J code" reimbursement? That's a regulatory change, not a holding. - The "generic guidance" is about protection, not conversion. Look for something like: "we have long held this asset, and now we are deliberately drawing on it." One thing: The company has a large installed base of relationships with surgeons, hospitals, payers. They are now leveraging that to expand into new areas? But that's not explicitly described as a long-held asset being converted. Another: The "EXPAREL" product itself has been on the market since 2011. They are now expanding indications, but that's not conversion of a holding. The question asks: "the company is cashing in an inheritance — something it already owns or has already earned, whose value was built up over time, is now being turned into operating business on purpose." Consider the "Surgeon Selector" tool and the "Choices Matter" campaign. They are building awareness, but that's new. Maybe the "J&J partnership" is not long-held. What about the "manufacturing capacity" in San Diego? They have been manufacturing for years. They are now scaling up in UK, but that's new. Perhaps the "nerve block" data? They have been studying for years, but that's not conversion. Another angle: The company has a large database of real-world evidence from Cleveland Clinic and Premier database for pediatric patients. They submitted that to FDA. That is using accumulated data to pursue a new indication. That could be a holding (data) being converted into regulatory approval, which would lead to business.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| HCKT | The Hackett Group, Inc. | Q1 2024 | 2024-05-08 | C |
| ASM | Avino Silver & Gold Mines Ltd. | Q4 2023 | 2024-03-21 | C+ |
| HUYA | HUYA Inc. | Q4 2023 | 2024-03-19 | C |
| NICE | NICE Ltd. | Q4 2023 | 2024-02-22 | B+ |
| SANG | Sangoma Technologies Corporation | Q2 2024 | 2024-02-08 | D |
| HP | Helmerich & Payne, Inc. | Q1 2024 | 2024-01-30 | C |
| OPAD | Offerpad Solutions Inc. | Q3 2023 | 2023-11-01 | C |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| PFIE | Profire Energy, Inc. | Q1 2023 | 2023-05-13 | B |
| ALGN | Align Technology, Inc. | Q4 2022 | 2023-02-01 | F |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| ZH | Zhihu Inc. | Q3 2021 | 2021-11-22 | D |
| IRBT | iRobot Corporation | Q3 2021 | 2021-10-28 | D |
| T | AT&T Inc. | Q3 2018 | 2018-10-24 | C+ |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| CP | Canadian Pacific Railway Limited | Q2 2018 | 2018-07-19 | B+ |
| ROK | Rockwell Automation, Inc. | Q4 2017 | 2017-11-08 | C |
| PTC | PTC Inc. | Q3 2017 | 2017-07-19 | C+ |
| BLKB | Blackbaud, Inc. | Q1 2017 | 2017-05-02 | B+ |
| VRNS | Varonis Systems, Inc. | Q2 2016 | 2016-08-09 | B+ |
T · Q3 2018 → YESThe question is: Does management describe that the company is NOW DELIBERATELY CONVERTING SOMETHING IT HAS LONG HELD OR LONG BUILT INTO CURRENT BUSINESS — an asset, position, etc., accumulated over ti...**YES** Management describes deliberately converting its long-held customer data and advertising inventory (built over years from the 25 million customer base and legacy TV slots) into a new advertising business via Xandr.
VRNS · Q2 2016 → YESThe question is about whether management describes converting something long-held into current business, that's still early. YES The transcript shows management describing the company's decade-plus of accumulated data-generation, audit, classification, and governance capabilities (explicitly "over a decade of experience" and "11 years") as the long-held foundation now being deliberately activated.
NICE · Q4 2023 → YESThe question is about whether management describes converting something long-held into current business, that's still early. YES The transcript shows management describing the deliberate conversion of a long-held asset—billions of historical CX interactions accumulated over years of platform operation—into current AI-driven business.